Project Grant R43HD116663
Award Date
9/1/24
Completion Date
8/31/25
Dollars Obligated
$333K
Federal Agency
National Institute of Child Health and Human Development
Federal Grant Program
93.865
Assistance Type
Project Grant
Place of Performance
Califon, NJ 07830, USA
Similar Awards
This $126,568 Project Grant, awarded on September 12, 2024 by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), supports the development of a novel, uterine-specific drug delivery system to treat preterm labor. The key products and services to be delivered through this funding include: Optimizing the physical-chemical parameters and antibody targeting of a poly(lactic-co-glycolic)...
This Project Grant award from the Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development provides $769,916 to Emergent Biotechnologies LLC for research into a novel therapy for preeclampsia. The funding supports Phase 1 of developing and characterizing a handle region peptide as an innovative treatment for preeclampsia under the Child Health and Human Development Extramural Research program (CFDA 93.865). Phase 1 work will...
This federal Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under CFDA 93.865 (Child Health and Human Development Extramural Research) aims to develop and evaluate water-soluble prodrugs of the novel therapeutic compound AKT-1005 for the treatment of preeclampsia. The $468,540 award to Beth Israel Deaconess Medical Center, Inc. (BIDMC) will fund research to synthesize and screen AKT-1005 prodrugs for improved solubility,...
The federal Project Grant award of $1,219,176 from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) will support the development and evaluation of a 3D printed, dose-flexible pediatric delivery system for treating toxoplasmosis in children. The project aims to create a single printlet system containing the drugs pyrimethamine, sulfadiazine, and leucovorin, which are currently difficult to...
This Project Grant award of $698,750 from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) aims to develop a targeted, placenta-tropic lipid nanoparticle (LNP) platform for delivering therapeutic mRNA cargo to the placenta to treat pre-eclampsia, a serious pregnancy condition. The key products and services to be delivered include: High-throughput screening of a large library of novel...
This Project Grant award of $248,999 from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), supports research to identify effective therapeutic agents for managing infection-induced preterm labor (III-PTL) and protecting against fetal inflammation. The key activities under this award include: 1) Optimizing a high-throughput screening assay to measure changes in pro-inflammatory cytokines...
The National Institute of Child Health and Human Development (NICHD) awarded a $2,283,054 Project Grant under CFDA 93.865, the Child Health and Human Development Extramural Research program, to CX Therapeutics, Inc. The grant aims to advance a novel medical device for treating cervical insufficiency, a pregnancy complication that can lead to preterm birth. Through this Phase II award, CX Therapeutics will finalize the device design, complete engineering verification, validate the device's...
The Project Grant award R43HD115425 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) is supporting Theranova LLC, a veteran-owned medical device R&D company, to conduct a pilot clinical study evaluating the SOLESTIM neuromodulation system as a home-use treatment for dysmenorrhea (primary menstrual cramps). The $343,510 award will fund a 16-week,...
This $380,692 Project Grant awarded by the National Institute of Child Health and Human Development (NICHD) under CFDA Program 93.865 (Child Health and Human Development Extramural Research) supports the development of an ultrapotent anti-sperm antibody construct for a non-hormonal contraceptive intravaginal ring. The funding will be used by Mucommune LLC, a biopharmaceutical company in Durham, North Carolina, to validate the safety and effectiveness of the LAMH10 antibody formulated into an...
The National Institute of Child Health and Human Development (NICHD) awarded a $306,778 Project Grant (CFDA 93.865 - Child Health and Human Development Extramural Research) to Orygyn Medical Devices, LLC, a small disadvantaged business based in Portland, Oregon. The funding supports the development of a novel Tubal Selective Delivery System (TSDS) device designed to safely and selectively administer fluids, foams, or gels to the fallopian tubes through a nonsurgical transcervical approach....